Cytel

Cytel

制药业

Cambridge,MA 71,599 位关注者

We help life science leaders unlock the power of data, solve their toughest problems, and make evidence-driven decisions

关于我们

Cytel is the world’s leading data-science CRO, driving advancements in human health through robust analytics and innovative clinical trial software. For nearly four decades, we have set the standard in adaptive trial design, leveraging extensive data insights to inform strategy throughout every phase of drug development and commercialization. Our mission is clear: accelerate drug development, enhance success rates, and deliver better patient outcomes. With a comprehensive suite of services from innovative trial design to end-to-end biometrics and real-world evidence, our specialized, multidisciplinary team ensures optimal strategies for preclinical research, trial execution, market access, and reimbursement. Headquartered in Cambridge, Massachusetts, Cytel has a global presence with over 2,000 employees across North America, Europe, and Asia. Learn more about how Cytel is harnessing the power of data to advance human health at www.cytel.com.

网站
https://www.cytel.com
所属行业
制药业
规模
1,001-5,000 人
总部
Cambridge,MA
类型
私人持股
创立
1987
领域
Adaptive Clinical Trials、Clinical Research Services、Trial Design and Analysis Software、Statistical Programming、Strategic Consulting、DMC Support、Program and Portfolio Optimization、Clinical Data Management、CV Outcomes Studies、Regulatory Submissions、Real World Analytics、HEOR、Bayesian Clinical Trials、FSP、Project Based Services和Advanced Analytics

地点

  • 主要

    675 Massachusetts Avenue

    US,MA,Cambridge,02139

    获取路线
  • 63 Avenue des Champs Elysées

    FR,Paris ,Paris ,75008

    获取路线
  • 2200 Renaissance Blvd

    Suite 370

    US,PA,King of Prussia ,19406

    获取路线
  • Lohia-Jain IT Park

    Chandni Chowk, Paud Road

    IN,Maharashtra,Pune,411038

    获取路线
  • ICC, Bat. C

    Route de Pré - Bois 20 C.P. 1839 12

    CH,Geneva

    获取路线
  • Hamilton House Mabledon Place

    Mabledon Place

    GB,Greater London ,London ,WC1H 9BB

    获取路线

Cytel员工

动态

  • 查看Cytel的公司主页,图片

    71,599 位关注者

    Navigating the EU JCA & Local HTA Processes Just Got Simpler! Are you facing challenges with EU Joint Clinical Assessments (JCAs) and local HTA decision-making? ?? The evolving landscape of health technology assessments (HTAs) in Europe demands clarity and strategy. Our free eBook is here to guide you! ?? What you’ll learn: ? Step-by-step strategies for navigating EU JCA submissions ? How to align with local HTA requirements seamlessly ? Insights to streamline your processes and improve decision-making Whether you’re in market access, regulatory affairs, or clinical development, this is a must-read! ?? Download the eBook now and stay ahead: https://hubs.ly/Q02ZN2PT0 #EUJCA #HTA #MarketAccess #Pharma #RegulatoryAffairs #HealthcareInnovation

    • 该图片无替代文字
  • 查看Cytel的公司主页,图片

    71,599 位关注者

    In this season of giving, we’re reminded of the incredible power of community, gratitude, and coming together. Yesterday, the Cytel team delivered meals and gift cards to McDevitt Middle School in Waltham, MA, helping ensure everyone can enjoy a warm and joyful Thanksgiving. ???? To our employees, clients, and partners: thank you for being part of our journey. Your support inspires us every day. We wish you and your loved ones a Thanksgiving filled with happiness, connection, and gratitude. Let’s continue to make a difference, together. ?? #Thanksgiving #Gratitude #CommunityImpact #ThankfulTogether

  • 查看Cytel的公司主页,图片

    71,599 位关注者

    ?? As the European Union Joint Clinical Assessment (EU JCA) progresses, the importance of country-specific Real-World Data (RWD) has never been greater. Claims databases and registries hold the potential to unlock critical insights into epidemiology, disease management, and economic burden at a national level. ?? Next week, join Marco Ghiani and Louis Chilotti as they explore how Real-World Evidence (RWE) can drive smarter strategies in the era of EU JCA. ?? Don’t miss this chance to learn how to target multiple countries with a single protocol! ?? Register now: https://hubs.ly/Q02ZG1J-0 #EUJCA #RealWorldData #HealthcareInnovation #EUJCA #RWE #RWD

    • 该图片无替代文字
  • 查看Cytel的公司主页,图片

    71,599 位关注者

    Read the post: https://hubs.ly/Q02ZvgnP0 #Vaccine efficacy trials, a critical component of public #health, differ from other late-phase #clinicaltrials and require special consideration. Haripria Ramesh Babu and Boaz Adler discuss how advanced simulation #software, like East Horizon – Explore, can help optimize trial designs and gain deeper insights into outcomes. #biotech #pharma #clinicaldevelopment #opensource #publichealth #Phase3

    • 该图片无替代文字
  • 查看Cytel的公司主页,图片

    71,599 位关注者

    ?? Exciting Day for Girls in STEM! ?? On November 16, 2024, the Cytel Geneva team hosted an incredible event dedicated to inspiring the next generation of female scientists and innovators! With the support of amazing employees from Cytel, we welcomed 400 enthusiastic girls aged 11 to 14 for a day filled with exploration and discovery. The event featured hands-on workshops led by talented female mentors from various businesses and academia in the local area. The participants dove into the fascinating worlds of Science and technology including programming, robotics, AI, virtual reality, and drones. In addition, our Discovery Fair showcased captivating stands discussing everything from the wonders of space travel and the chemistry behind perfumery to the groundbreaking experiments at CERN, home of the famous Hadron Collider! This event was all about empowering young girls to dream big and consider exciting future careers in STEM. A huge thank you to everyone involved for making this day such a success! Let’s continue to inspire and support girls on their journey towards a brighter future in science and technology! #GirlsInSTEM #Inspiration #STEMCareers #Cytel #eth_geneve

    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
  • 查看Cytel的公司主页,图片

    71,599 位关注者

    In our of our most recent blogs with Ann-Kristin Spiik, we dove deeper into the topic of oligotherapeutics, one of the most promising and exciting pharmaceutical development, especially for rare diseases. How many ASO therapies for different rare diseases have received FDA or EMA approval up to now? If you don’t know and want a hint, best to check out our blog again on https://lnkd.in/gAt7b_sU ??

    此处无法显示此内容

    在领英 APP 中访问此内容等

  • 查看Cytel的公司主页,图片

    71,599 位关注者

    The clinical research landscape is evolving rapidly, and the FDA's latest guidance on integrating real-world clinical trials (RCTs) into clinical practice is a game-changer. As the potential of Real-World Evidence (RWE) grows, understanding these developments is essential to staying ahead. Join Massoud Toussi and Yannis Jemiai for The Evidence Base Office Hours as we unpack the key implications of this new guidance and explore how it could shape your work in clinical trials. Register here: https://hubs.ly/Q02Z0Tv30 #FDA #RWE #RealWorldEvidence

    • 该图片无替代文字

关联主页

相似主页

查看职位

融资